Center for Vein Restoration - Comprehensive Analysis Report

Summary

Center for Vein Restoration (CVR) is the largest physician-led practice in the United States dedicated to the treatment of vein disease. Founded in 2007 by Dr. Sanjiv Lakhanpal, a cardiovascular and thoracic surgeon, CVR's mission is to improve lives by providing state-of-the-art vascular care that is both compassionate and affordable. The company aims to redefine the care of patients with venous disorders by offering comprehensive vein care across the U.S., fostering clinical excellence, integrity, mutual respect, and trust. CVR is a national leader in the diagnosis and treatment of conditions such as varicose veins and spider veins, which stem from chronic venous insufficiency, emphasizing personalized, positive treatment options in an office-based setting.

1. Strategic Focus & Objectives

Core Objectives

CVR's main business mandate is to provide comprehensive, individualized, and affordable treatment for chronic venous insufficiency (CVI).

Short-term goals: Connect individuals suffering from CVI with local centers for appropriate diagnosis and treatment, enabling them to live pain-free lives.
Long-term goals: Continuously redefine patient care for venous disorders and expand its network to serve more communities across the United States.

Specialization Areas

CVR specializes in advanced diagnostic and treatment services for all grades of chronic venous insufficiency.

Key areas of expertise: Ultrasounds, ablations (radiofrequency and laser), sclerotherapy (including ultrasound-guided foam sclerotherapy), Varithena, and VenaSeal.
Unique value propositions: Highly trained physicians, state-of-the-art equipment, a commitment to patient-focused approaches that address the root causes of vein disease, and a dual focus on improving both patient appearance and quality of life. The company also maintains the largest venous database in the country, contributing to research and education.

Target Markets

CVR targets individuals experiencing chronic venous insufficiency (vein disease).

Primary market segments: Patients suffering from symptoms such as achy, tired, and heavy legs, varicose veins, spider veins, skin changes, and venous ulcerations.
Market positioning strategy: Positioned as an accessible, specialized provider of minimally invasive, office-based vein treatments, with an expanding footprint of over 100 locations across 23 states.

2. Financial Overview

Funding History

Center for Vein Restoration is a privately held company.

Total funds raised to date: The company has raised $176 million.
Acquisition: CVR was acquired by Cortec Group in January 2016. Financial details of the acquisition were not publicly disclosed. During Waud Capital Partners' ownership, CVR expanded its clinics from 11 to 44 and operated in eight states.
Estimated Annual Revenue: The company has an estimated annual revenue of $201.2 million per year, with other sources indicating a revenue range of $100 to $250 million.
Revenue Model: CVR generates revenue through a fee-for-service model, with procedures priced based on complexity. The company collaborates with major insurance providers, including Medicare and Medicaid, with a significant portion of its revenue derived from reimbursements.

3. Product Pipeline

Key Products/Services

CVR provides a range of minimally invasive outpatient procedures for venous insufficiency.

Ultrasounds:
Description: Advanced diagnostic method to identify the extent and severity of venous insufficiency.
Development stage: Established and widely used diagnostic tool.
Target market/condition: Patients with suspected or diagnosed chronic venous insufficiency.
Key features and benefits: Non-invasive, provides detailed imaging of veins, crucial for accurate diagnosis.

Ablations (Radiofrequency Ablation and Laser Ablation):
Description: Procedures that use heat (radiofrequency or laser energy) to close off diseased veins.
Development stage: Well-established, FDA-approved, and routinely performed.
Target market/condition: Patients with refluxing superficial veins, commonly associated with varicose veins.
Key features and benefits: Minimally invasive, high success rates, quick recovery, performed in an office setting.

Sclerotherapy (including Ultrasound-Guided Foam Sclerotherapy):
Description: Involves injecting a solution (sclerosant) into the vein, causing it to close and fade. Ultrasound-guided foam sclerotherapy allows for treatment of larger or deeper veins not visible on the surface.
Development stage: Established and widely used treatment.
Target market/condition: Spider veins, smaller varicose veins, and some larger or deeper incompetent veins.
Key features and benefits: Effective for cosmetic improvement and symptom relief, suitable for various vein sizes, minimally invasive.

Varithena:
Description: A proprietary foam sclerosant delivered via a catheter into the diseased vein, collapsing and sealing it.
Development stage: Established, FDA-approved treatment.
Target market/condition: Patients with incompetent great saphenous veins (GSV), small saphenous veins (SSV), and accessory saphenous veins.
Key features and benefits: Non-thermal, non-tumescent, minimally invasive, can treat a wide range of vein sizes and tortuosity.

VenaSeal:
Description: Uses a medical adhesive to close the diseased vein.
Development stage: Established, FDA-approved treatment.
Target market/condition: Patients with symptomatic venous reflux in the great saphenous vein.
Key features and benefits: Non-thermal, non-tumescent, immediate patient recovery, does not require multiple needle sticks for local anesthesia.

4. Technology & Innovation

Technology Stack

CVR employs advanced technologies and methodologies for vein care.

Core platforms and technologies: Advanced, minimally invasive outpatient procedures.
Proprietary developments: The company maintains the largest venous database in the country, from which it annually publishes research. CVR is also the only non-academic vein group with an American Board of Venous & Lymphatic Medicine (ABVLM) accredited venous and lymphatic medicine fellowship program, a 12-month post-graduate medical education training program.
Scientific methodologies: Utilizes diagnostic ultrasounds and modern vein closure techniques such as radiofrequency ablation, laser ablation, sclerotherapy, Varithena, and VenaSeal.
Technical capabilities: High education and training standards for its physicians and vascular technicians, supported by modern operational tools like Microsoft 365, Sendinblue, and HTML5.

5. Leadership & Management

Executive Team

The leadership team at Center for Vein Restoration drives strategic initiatives for organizational growth and patient care.

Sanjiv Lakhanpal, MD, FACS - Founder, President, and CEO
Professional background: Highly respected cardiovascular and thoracic surgeon, board-certified in general surgery, cardiovascular surgery, and thoracic surgery. Previously director of minimally invasive cardiac surgery at Washington Adventist Hospital and director of cardiac surgery at Prince George's Hospital Center.
Notable achievements: Founded CVR in 2007; also founded the Center for Vascular Medicine (CVM), specializing in deep venous disorders and peripheral arterial disease (PAD).
Key contributions: Established the company's vision and commitment to exceptional, affordable vein disease treatment.
LinkedIn: https://www.linkedin.com/in/sanjiv-lakhanpal-09a4358a

Khanh Q. Nguyen, DO, RPVI - Chief Medical Officer
Professional background: Board Certified Physician and Registered Physician in Vascular Interpretation with extensive training in ultrasound and vascular access.
Notable achievements: Received the President's Award for unparalleled service to CVR in 2020; his work in venous disease has been nationally published.
Key contributions: Oversees clinical excellence and medical protocols.

Ken Abod - Chief Financial Officer
Professional background: Over 30 years of executive experience leading and managing high-growth healthcare providers; background in developing financial infrastructures and leading growth strategies and M&A. Previously EVP/CFO at MyEyeDr and SVP & Treasurer at Hanger, Inc.
Key contributions: Manages CVR's financial health and growth strategies.

Jon Felts - Chief Operating Officer
Professional background: Over 20 years of experience in healthcare and retail industries, including a Fortune 50 company; experience in healthcare practice management for organizations with up to 1,000 employees and 150 doctors. Graduate of The Georgetown University Leadership Coaching Program.
Key contributions: Oversees operational efficiency and scalability.

Wendy Walker, SPHR - Vice President of Human Resources
Professional background: Over 30 years of business management experience and more than 15 years as a leader in human resources. Certified as a Senior Professional in Human Resources.
Key contributions: Manages talent acquisition, employee development, and human resources strategies.

Robert Howell - Vice President, New Growth And Development
Key contributions: Focuses on identifying and implementing new growth opportunities for the company.

Recent Leadership Changes

August 2025: Dr. Omonuwa Adah joined CVR as a new vein doctor.
February 2026: Dr. Frank Sagato joined as a vein health expert in New Hampshire.
October 2025: Dr. Victor Medina joined as a vein specialist in Cary, NC.
Undated: Dr. Philip Moore joined CVR in Texas.

6. Talent and Growth Indicators

Hiring Trends and Workforce

Center for Vein Restoration has a workforce of over 600 employees, with other estimates ranging from 227 to 596 employees. The company's employee count reportedly grew by 12% in the past year.

Key roles being recruited: Vein Physicians are actively being sought.
Company growth trajectory indicators: Expansion to over 100 locations across 23 states, conducting over 200,000 patient interactions annually, and plans to almost double its current size in the outpatient setting within the next two years.
Employee sentiment and culture insights: CVR fosters a work environment emphasizing a shared passion for helping people with chronic venous insufficiency. Employees express a sense of purpose and belonging, with positive work culture feedback. Clinical staff can enjoy a 4-day work week and a bonus program based on clinic performance.
Company size and expansion metrics: Over 100 locations in 23 states, significant growth from 11 clinics to 44 during previous ownership.

7. Social Media Presence and Engagement

Digital Footprint

Center for Vein Restoration maintains an active digital presence across multiple social media platforms.

Social media activity across platforms: Active on Facebook, Twitter (now X), and YouTube.
Brand messaging and positioning: Focuses on raising awareness about chronic venous insufficiency, educating the public on symptoms and treatment options, and highlighting the benefits of minimally invasive procedures.
Community engagement strategies: Features patient testimonials and utilizes platforms to promote the annual VISION conference, a key event for healthcare professionals in venous and lymphatic medicine.
Thought leadership initiatives: Videos from CEO Dr. Sanjiv Lakhanpal discussing the company's origins and future are available on their YouTube channel.

8. Recognition and Awards

Industry Recognition

Center for Vein Restoration has received multiple awards and recognitions for its workplace culture, clinical excellence, and leadership.

2021 Top Workplaces USA award: Awarded by Energage, based on employee feedback for strong employee engagement.
2021 Top Workplaces in the Healthcare Industry Award: Also from Energage.
Lakhanpal Vein Foundation Sushruta Award: Presented by Dr. Lakhanpal to prominent physicians and leaders in venous study, such as Anthony J. Comerota, MD (2023) and Dean Bender (2020), recognizing brilliance, boldness, knowledge propagation, collaboration, and a holistic approach.
President's Award: Awarded to physicians for exceptional commitment to venous medicine and contributions to CVR (e.g., Dr. Khanh Nguyen in 2020).
2022 Company Recognitions (internal awards): Included Top Newcomer (Salisbury, MD), Top Center (Lakewood, NJ), Top Region (Michigan West), Top Engaged Physician (Vinay Satwah, DO, RPVI), Top Physician Liaison (Nina Soto), Top IT Professional (Gerson Lopez), Top Patient Services Agent (Joanne Ganz), Top Revenue Cycle Management Team Member (Griselda Rodriguez), Unsung Hero (Brian Rumble), Top Department (IT), and Top Director (Betelhem Worku).
Glassdoor Top CEO award winner: Dr. Sanjiv Lakhanpal received this in 2019.
Research Publications: CVR's team has been published in peer-reviewed journals including The New England Journal of Medicine, the Journal of Vascular Surgery, and Phlebology, demonstrating their commitment to advancing the field.

9. Competitive Analysis

Major Competitors

Center for Vein Restoration operates in a competitive market for vascular disease treatment, particularly within the clinics/outpatient services industry.

USA Vein Clinics:
Company overview: Provides a range of vein treatments, often focusing on varicose and spider veins.
Focus areas: Minimally invasive vein care, similar to CVR.
Technological capabilities: Utilizes procedures such as endovenous laser treatment, radiofrequency ablation, and sclerotherapy.

Palm Vascular Centers:
Company overview: Offers comprehensive vascular care.
Focus areas: Diagnosis and treatment of various vascular conditions, including peripheral arterial disease and venous insufficiency.

United Vein and Vascular Centers:
Company overview: Specializes in the diagnosis and treatment of venous disease.
Focus areas: Comprehensive vein care, including varicose veins and spider veins.
Technological capabilities: Employs advanced techniques like laser ablation and phlebectomy.

Metro Vein Centers:
Company overview: Focuses on the treatment of vein disease.
Focus areas: Varicose veins, spider veins, and other venous conditions.
Technological capabilities: Offers various minimally invasive procedures.

Vein Clinics:
Company overview: A broad term that encompasses many specialized vein treatment centers.
Focus areas: Generally specialize in cosmetic and medical vein treatments.

Other noted competitors include Key Point Health Services, Coronis Health, UM Shore Regional Health, Biote, Physician's Services, Inc., and NRAD Medical Associates, indicating a diverse and evolving landscape of healthcare providers in related fields.

10. Market Analysis

Market Overview

Chronic venous insufficiency (CVI) is a significant and often underdiagnosed condition in the United States.

Total addressable market size: CVI affects an estimated 30 to 40 million Americans.
Growth potential: The market for venous disease treatment is experiencing growth due to increasing awareness, an aging population, and a shift towards minimally invasive outpatient procedures. CVR's expansion to over 100 locations across numerous states demonstrates strong market demand.
Key market trends: A notable trend is the move towards office-based, minimally invasive procedures, which offer quicker recovery times and convenience for patients. Increased patient education and accessibility to specialized care are also driving market growth.
Market challenges and opportunities: While CVI is widespread, it is often underdiagnosed, presenting an opportunity for increased public awareness campaigns and diagnostic initiatives. Competition in the specialized vein care market is growing, requiring continuous innovation and patient satisfaction to maintain leadership.

11. Strategic Partnerships

Center for Vein Restoration actively pursues strategic collaborations to expand its network and services.

Partner organization: Dr. Calcagno and Dr. Rossi of the Vein Treatment Center in Mechanicsburg, PA.
Nature of partnership: Acquisition allowing CVR to reach its 100th center nationwide in 2021.
Strategic benefits: Expanded geographic reach and integrated established practices into CVR's network.

Partner organization: Vein Specialists of the Carolinas.
Nature of partnership: Partnership in August 2024.
Strategic benefits: Allowed the existing team to continue providing patient care while benefiting from CVR's nationwide network and technologies.

Annual VISION conference:
Nature of partnership: A platform that brings together physicians and industry partners.
Strategic benefits: Fosters discussion and collaboration on advancements in venous and lymphatic medicine, promoting collective growth and innovation within the industry.

12. Operational Insights

Center for Vein Restoration's operational model emphasizes specialization, accessibility, clinical excellence, and patient satisfaction.

Current market position: CVR is positioned as the largest physician-led practice solely focused on venous disease in the nation.
Competitive advantages:
Specialized expertise: Deep focus on venous disease translates to comprehensive and expert care.
Extensive network: Over 100 clinics across 23 states provide wide accessibility.
Clinical excellence: High education and training standards, an ABVLM-accredited fellowship program, and consistent research publications reinforce its leadership.
Minimally invasive approach: Offers a wide range of FDA-approved, office-based treatment modalities.
Patient-centric care: Aims for safe, personalized, and positive treatment experiences, contributing to a high patient satisfaction rate of 98 percent.
* Operational strengths: Standardized protocols across its numerous locations ensure consistent quality of care. The company's